Mayo Clinic Jacksonville scientists show that specially created molecules can cross blood-brain barrier

JACKSONVILLE, Fla., July 1, 1999 -- Mayo Clinic Jacksonville scientists have shown that a specially created molecule injected into the belly of a rat can cross the nearly impassable blood-brain barrier and can stop the chemical reaction in the brain that the molecule was designed to impede.

The discovery is an amazing and unexpected finding. It could some day lead to drugs specifically created to fight disease at the molecular level, says Dr. Elliott Richelson.

Richelson and his colleagues in the Neuropsychopharmacology and Neurochemistry labs at Mayo Jacksonville and the Department of Biochemistry and Molecular Biology at Mayo Clinic Rochester described their findings in the June 8 issue of the Proceedings of the National Academy of Sciences.

Richelson has been studying neurotensin, a small piece of protein, or peptide, found in the brain and involved in pain perception and lowering body temperature. For the last few years, scientists worldwide have been testing the theory that interfering with a protein's production on a molecular level might stop it from carrying out its job in humans. Scientists were trying to interfere with protein production by creating special "antisense" molecules designed to block a cell's ability to make specific proteins.

To better understand the brain peptide he was researching, Richelson and his colleagues used peptide nucleic acids (PNAs), a new type of molecule, to create antisense compounds targeting neurotensin. When they injected the PNA antisense molecules into the brains of rats, the molecules worked. They blocked neurotensin's ability to lower body temperature and reduced its ability to block the sensation of pain.

"Then we injected PNA in the belly of the rat to see what would happen, and we got the same result," Richelson says. "Nobody had ever shown that you could inject this type of molecule or any type of antisense molecule in the belly and get a biological response in the brain."

That's importan

Contact: Evelyn Tovar
Mayo Clinic

Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Clinical judgement still counts strongly alongside genetic testing
4. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
5. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
6. St. Jude/Mayo Clinic study finds direct link between CBP gene and lymphoma
7. DFG to establish seven new Clinical Research Units
8. Clinical trial patients dont care about study sponsors or physician conflicts of interest
9. NIH establishes Rare Diseases Clinical Research Network
10. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
11. Clinical study reports findings of combination therapy with DOXIL

Post Your Comments:

(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, ... capital firm that provides patent development support for early stage startups. The investment ... such as ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical ...
(Date:4/22/2020)... ... April 21, 2020 , ... Worcester Polytechnic Institute (WPI) is expanding an existing ... to address the expected spike of COVID-19 cases. As part of its longtime Math ... 3D printers and other materials to be sent to six countries to facilitate the ...
(Date:4/18/2020)... ... April 17, 2020 , ... ... uses magnetic nano-beads to isolate minute bacterial particles that cause diseases. Using ... and difficult-to-detect micro-particles such as those making up Ebola and coronaviruses. , ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... 2020 , ... Experienced periodontist in Eden Prairie, MN, Dr. Andres Sanchez, offers ... PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently cut bone in the ... dental implants, especially when the implants need to be placed in a sensitive area ...
(Date:5/21/2020)... ... May 20, 2020 , ... Exo ... will serve as the company’s executive vice president of product engineering and report ... disrupting the medical imaging space, bringing more than 24 years of technology leadership ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... multiple open heart surgeries before becoming adults. The reason: there are ... address this critical unmet need, the Department of Defense has awarded Draper, Boston ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board of Directors, ... closely with CEO Brian Miller and Sentien’s management team. , Mr. Ganz ...
Breaking Biology Technology:
Cached News: